person

Anne Hauge T.

Country
Denmark
Department
Nuclear Medicine

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 1 partner site.

Specializations

Oncology – Solid Tumors

The investigator focuses on therapeutic strategies for breast cancer, non‑small cell lung cancer, melanoma, ovarian cancer, and colorectal cancer.

  • Targeted therapies for HER2‑positive disease
  • Immuno‑oncology approaches in metastatic settings
  • Biomarker‑driven treatment selection

Research integrates advanced imaging modalities to assess treatment response.

Hematologic Malignancies

Key interests include acute myeloid leukemia, acute lymphoblastic leukemia, various forms of lymphoma, and multiple myeloma.

  • Novel agents for refractory disease
  • Combination regimens with targeted inhibitors
  • Minimal residual disease monitoring

Efforts aim to improve survival outcomes across disease stages.

Cardiovascular and Metabolic Medicine

Research addresses acute myocardial infarction, atrial fibrillation, heart failure, as well as metabolic conditions such as type 2 diabetes and obesity.

  • Risk reduction after ischemic events
  • Antithrombotic strategies in high‑risk patients
  • Metabolic modulation to prevent cardiovascular complications

Clinical insights are derived from imaging‑guided patient stratification.

Respiratory and Pulmonary Disorders

Focused on severe asthma, chronic obstructive pulmonary disease, bronchiectasis, and infections such as nontuberculous mycobacterial lung disease.

  • Biologic therapies for eosinophilic inflammation
  • Management of frequent exacerbations
  • Precision diagnostics using nuclear imaging

Goals include reducing hospitalization and improving lung function.

Autoimmune and Neurologic Diseases

Investigations span Alzheimer’s disease, multiple sclerosis, systemic lupus erythematosus, and vasculitic disorders such as ANCA‑associated vasculitis.

  • Neuroprotective interventions
  • Immune modulation in systemic autoimmunity
  • Imaging biomarkers for disease activity

Therapeutic development targets disease progression and quality of life.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.